title: Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice.
abstract: The incidence of mycobacterial diseases is high and the efficacy of Bacillus Calmette Guerin (BCG) is low in most areas of the world where chronic worm infections are common. However, if and how concurrent worm infections could affect immunity to mycobacterial infections has not been elucidated. In this study we investigated whether infection of mice with Schistosoma mansoni could affect the ability of the animals to control Mycobacterium bovis BCG infection and the immune response to mycobacterial antigens. BALB/c mice subclinically infected with S. mansoni were challenged with M. bovis BCG via the intravenous route. The ability of the animals to contain the replication of M. bovis BCG in their organs, lung pathology as well as the in vitro mycobacterial and worm antigen induced immune responses were evaluated. The results showed that S. mansoni coinfected mice had significantly higher levels of BCG bacilli in their organs and sustained greater lung pathology compared to Schistosoma uninfected controls. Moreover, Schistosoma infected mice show depressed mycobacterial antigen specific Th1 type responses. This is an indication that chronic worm infection could affect resistance/susceptibility to mycobacterial infections by impairing mycobacteria antigen specific Th1 type responses. This finding is potentially important in the control of TB in helminth endemic parts of the world.
authors.affiliation: Microbiology and Tumour Biology Centre, Karolinska Institute, Stockholm, Sweden. eliasroro@yahoo.com
authors.forename: D
authors.initials: D
authors.lastname: Elias
authors.forename: H
authors.initials: H
authors.lastname: Akuffo
authors.forename: C
authors.initials: C
authors.lastname: Thors
authors.forename: A
authors.initials: A
authors.lastname: Pawlowski
authors.forename: S
authors.initials: S
authors.lastname: Britton
mesh_terms: D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D000947:Antigens, Helminth / Q000276:immunology; D002908:Chronic Disease; D004198:Disease Susceptibility; D005260:Female; D007371:Interferon-gamma / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D023421:Models, Animal; D009163:Mycobacterium bovis; D012550:Schistosoma mansoni; D012555:Schistosomiasis mansoni / Q000276:immunology* / Q000382:microbiology; D018417:Th1 Cells / Q000276:immunology; D014376:Tuberculosis / Q000276:immunology* / Q000469:parasitology
chemical_list: D000942:Antigens, Bacterial; D000947:Antigens, Helminth; D007371:Interferon-gamma
references.citation: Bull World Health Organ. 2000;78(11):1368-9
references.pmid: 11143198
references.citation: J Immunol. 1991 Oct 15;147(8):2713-6
references.pmid: 1680917
references.citation: J Immunol. 1995 Aug 15;155(4):2057-66
references.pmid: 7543537
references.citation: Infect Immun. 1999 Jun;67(6):2867-73
references.pmid: 10338493
references.citation: Braz J Med Biol Res. 1999 Nov;32(11):1429-36
references.pmid: 10559845
references.citation: Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):948-52
references.pmid: 8094248
references.citation: J Exp Med. 1991 Jan 1;173(1):159-66
references.pmid: 1824635
references.citation: Curr Opin Immunol. 2001 Aug;13(4):417-28
references.pmid: 11498297
references.citation: Infect Immun. 2001 Mar;69(3):1574-80
references.pmid: 11179329
references.citation: J Clin Invest. 1993 Oct;92(4):1667-73
references.pmid: 8408619
references.citation: Parasitol Today. 1997 Nov;13(11):438-43
references.pmid: 15275146
references.citation: J Immunol. 1992 May 15;148(10):3264-70
references.pmid: 1533656
references.citation: J Infect Dis. 2004 Jul 1;190(1):123-6
references.pmid: 15195251
references.citation: Science. 2000 Jun 23;288(5474):2131
references.pmid: 10896582
references.citation: Scand J Infect Dis. 2001;33(8):568-71
references.pmid: 11525348
references.citation: J Immunol. 1999 Jun 1;162(11):6843-8
references.pmid: 10352306
references.citation: Immunology. 2001 May;103(1):1-9
references.pmid: 11380686
references.citation: Lancet. 2003 Sep 13;362(9387):887-99
references.pmid: 13678977
references.citation: J Infect Dis. 1997 Nov;176(5):1351-9
references.pmid: 9359738
references.citation: JAMA. 1999 Aug 18;282(7):677-86
references.pmid: 10517722
references.citation: Biochem Biophys Res Commun. 2001 Apr 20;282(5):1169-76
references.pmid: 11302738
references.citation: Curr Opin Microbiol. 1999 Feb;2(1):89-93
references.pmid: 10047556
references.citation: Clin Exp Immunol. 2001 Feb;123(2):219-25
references.pmid: 11207651
references.citation: J Immunol. 1993 Nov 1;151(9):4857-64
references.pmid: 8409444
references.citation: J Parasitol. 1978 Jun;64(3):285-90
references.pmid: 566313